Neuroone Medical Technologies (NMTC) EBITDA Margin (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,884.00 |
| Dec 31, 2025 | -900.00 |
| Sep 30, 2025 | 6,121.00 |
| Jun 30, 2025 | 8,205.00 |
| Mar 31, 2025 | -24,555.00 |
| Dec 31, 2024 | 108,675.00 |
| Sep 30, 2024 | -69,615.00 |
| Jun 30, 2024 | -12,879.00 |
| Mar 31, 2024 | 13,725.00 |
| Dec 31, 2023 | 7,984.00 |
| Sep 30, 2023 | 13,062.00 |
| Jun 30, 2023 | 19,265.00 |
| Mar 31, 2023 | 80,740.00 |
| Dec 31, 2022 | 47,821.00 |
| Sep 30, 2022 | 658,076.00 |
| Jun 30, 2022 | -25,249.00 |
| Mar 31, 2022 | -3,937.00 |
| Dec 31, 2021 | -285,412.00 |
| Sep 30, 2021 | 209,903.00 |
| Jun 30, 2021 | 556,495.00 |
| Mar 31, 2021 | -1.01 Mn |
| Jun 30, 2014 | -292,437.00 |
| Jun 30, 2013 | -254,527.00 |
| Mar 31, 2013 | -35,550.00 |
| Dec 31, 2012 | 2.02 Mn |
| Mar 31, 2012 | 145,029.00 |
| Dec 31, 2011 | -469,659.00 |